Skip to main content

What the FDA labels say about taking them together

Bupropion and telotristat

Telotristat's FDA label of August 6, 2026 names bupropion in its drug interactions section; the bupropion labels PlainMeds reads (4) do not name telotristat. The telotristat label: “Concomitant use of Xermelo may decrease the efficacy of drugs that are CYP2B6 substrates by decreasing their systemic exposure.”

Check it at the source: the bupropion FDA label on DailyMed (effective June 21, 2024); the telotristat FDA label on DailyMed (effective August 6, 2026).

What does the bupropion label say about telotristat?

Bupropion's label (effective June 21, 2024) and its 3 other brand-application labels do not name telotristat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (BUPROPION HYDROCHLORIDE), Epic Pharma LLC, effective June 21, 2024 (SPL set 9fb44e96-6160-4a4a-90cb-91764c0dcd89), via openFDA; the full label on DailyMed

What does the telotristat label say about bupropion?

Telotristat label, drug interactions

Concomitant use of Xermelo may decrease the efficacy of drugs that are CYP2B6 substrates (e.g., bupropion, efavirenz) by decreasing their systemic exposure.

Source: FDA drug label (Xermelo), TerSera Therapeutics LLC, effective August 6, 2026 (SPL set a4ac9d62-887c-4c8f-b04d-a5f31cec7c86), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

69Bupropion generic labelers
0Telotristat generic labelers
BupropionTelotristat
Labeled forDepression, Quitting smokingDiarrhea
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0785 per tablet 150 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?